Fluoroquinolones

DRUG2 trials

Sponsors

Northwell Health, Qingfeng Pharmaceutical Group

Conditions

Community Acquired PneumoniaKidney Stones

Phase 3

Trial of Randomized Antibiotic Administration in Percutaneous Nephrolithotomy

CompletedNCT02579161

Northwell HealthKidney Stones

Start: 2014-09-30End: 2018-12-31Updated: 2023-09-06

Phase 4

Adjunctive Therapy of Andrographolid Sulfonatein Community Acquired Pneumonia

Qingfeng Pharmaceutical GroupCommunity Acquired Pneumonia

Start: 2016-07-31End: 2019-06-30Target: 462Updated: 2018-04-10

Related Papers

Andrographolide Sulfonate Injection for Adjunctive Treatment of Non-severe Community-Acquired Pneumonia in Adults: A Multicenter, Double-Blind, Randomized Controlled Trial.

2026-01-05

Prospective Randomized Trial of Antibiotic Prophylaxis Duration for Percutaneous Nephrolithotomy in Low-Risk Patients

Journal of Endourology2023-08-142 citations